Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancer

Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancer

US Patent 12076400 · Granted Sep 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Multivalent and bispecific antibody constructs and methods of use thereof2025
Bispecific antigen binding constructs targeting HER22025
Methods of using bispecific antigen-binding constructs targeting HER22024
Bispecific antigen-binding constructs targeting HER22024
Bispecific antigen-binding constructs targeting Her22022
Bispecific antigen-binding constructs targeting HER22021
Bispecific antigen-binding constructs targeting HER22018
MUC1 based glycolipopeptide vaccine with adjuvant2014
MUC1 based glycolipopeptide vaccine with adjuvant2012
Method for analyzing molecular expression or function in an intact single cell2002